Revenue, 2025
USD 9.41 Bn
Forecast Year, 2034
USD 14.23 Bn
CAGR, 2025 - 2034
4.70%
Report Coverage
Worldwide
The global glaucoma market, valued at over USD 9.41 billion in 2025, is projected to grow to approximately USD 14.23 billion by 2034, expanding at a CAGR of 4.7%, driven by rising prevalence, early diagnosis, and innovative therapies."
Glaucoma Market Size Analysis
Glaucoma Market Size By Disease Type 2025 to 2034 (USD Billion)
| Disease Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Open Angle Glaucoma | 6.11 | 6.40 | 6.70 | 7.01 | 7.34 | 7.69 | 8.05 | 8.43 | 8.82 | 9.24 |
| Angle Closure Glaucoma | 2.36 | 2.47 | 2.58 | 2.70 | 2.83 | 2.96 | 3.10 | 3.25 | 3.40 | 3.56 |
| Other | 0.94 | 0.99 | 1.03 | 1.08 | 1.13 | 1.19 | 1.24 | 1.30 | 1.36 | 1.43 |
Glaucoma Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Prostaglandin Analog | 3.19 | 3.34 | 3.50 | 3.66 | 3.83 | 4.01 | 4.20 | 4.40 | 4.61 | 4.82 |
| Beta Blockers | 2.07 | 2.17 | 2.27 | 2.37 | 2.49 | 2.60 | 2.72 | 2.85 | 2.99 | 3.13 |
| Adrenergic Agonist | 1.51 | 1.58 | 1.65 | 1.73 | 1.81 | 1.90 | 1.99 | 2.08 | 2.18 | 2.28 |
| Carbonic Anhydrase Inhibitors | 1.70 | 1.78 | 1.86 | 1.95 | 2.04 | 2.14 | 2.24 | 2.34 | 2.45 | 2.57 |
| Others | 0.95 | 0.99 | 1.04 | 1.09 | 1.14 | 1.19 | 1.25 | 1.30 | 1.37 | 1.43 |
Glaucoma Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 3.95 | 4.13 | 4.33 | 4.53 | 4.74 | 4.97 | 5.20 | 5.44 | 5.70 | 5.97 |
| Retail Pharmacy | 3.58 | 3.75 | 3.92 | 4.11 | 4.30 | 4.50 | 4.71 | 4.93 | 5.17 | 5.41 |
| Online Pharmacy | 1.89 | 1.98 | 2.07 | 2.17 | 2.27 | 2.37 | 2.48 | 2.60 | 2.72 | 2.85 |
Glaucoma Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.57 | 3.74 | 3.91 | 4.09 | 4.29 | 4.49 | 4.70 | 4.92 | 5.15 | 5.39 |
| Europe | 2.45 | 2.56 | 2.68 | 2.81 | 2.94 | 3.08 | 3.22 | 3.37 | 3.53 | 3.70 |
| Asia Pacific | 2.07 | 2.17 | 2.27 | 2.38 | 2.49 | 2.61 | 2.73 | 2.86 | 2.99 | 3.13 |
| Latin America | 0.76 | 0.79 | 0.83 | 0.87 | 0.91 | 0.95 | 1.00 | 1.04 | 1.09 | 1.14 |
| Middle East and Africa | 0.57 | 0.59 | 0.62 | 0.65 | 0.68 | 0.71 | 0.75 | 0.78 | 0.82 | 0.86 |
Glaucoma Market Size to Attain USD 14.23 Billion by 2034
The global glaucoma market size surpassed USD 9.41 billion in 2025 and is predicted to reach around USD 14.23 billion by 2034 a CAGR of 4.70%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com